Belpointe Asset Management’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
Other funds holding BME
NRW
CA
Belpointe Asset Management's BME Position: Q2 2023 in Review
Belpointe Asset Management sold out of BlackRock Health Sciences Trust (BME) in Q2 2023, closing a stake of 1,568 shares — an estimated $65.6K sold.
Belpointe Asset Management first reported a position in BME in Q4 2022 and held it in 2 quarters. The position peaked at $111K in Q4 2022. 69 funds tracked by Wall St. Rank hold BME as of Q2 2023.
- Belpointe Asset Management reported no remaining BlackRock Health Sciences Trust position as of Q2 2023 after selling out during the quarter.
- Belpointe Asset Management sold 1,568 BlackRock Health Sciences Trust shares in Q2 2023, an estimated $65.6K.
- Belpointe Asset Management first reported a position in BlackRock Health Sciences Trust in Q4 2022 and held it in 2 quarters.
- Belpointe Asset Management's BlackRock Health Sciences Trust position peaked at $111K in Q4 2022.
- 69 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2023.
Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.